[HTML][HTML] Are whole-exome and whole-genome sequencing approaches cost-effective? A systematic review of the literature

K Schwarze, J Buchanan, JC Taylor, S Wordsworth - Genetics in Medicine, 2018 - Elsevier
Purpose We conducted a systematic literature review to summarize the current health
economic evidence for whole-exome sequencing (WES) and whole-genome sequencing …

Pharmacogenomics in the clinic

MV Relling, WE Evans - Nature, 2015 - nature.com
After decades of discovery, inherited variations have been identified in approximately 20
genes that affect about 80 medications and are actionable in the clinic. And some …

[HTML][HTML] The complete costs of genome sequencing: a microcosting study in cancer and rare diseases from a single center in the United Kingdom

K Schwarze, J Buchanan, JM Fermont, H Dreau… - Genetics in …, 2020 - Elsevier
Purpose The translation of genome sequencing into routine health care has been slow,
partly because of concerns about affordability. The aspirational cost of sequencing a …

Is the $1000 genome as near as we think? A cost analysis of next-generation sequencing

KJM van Nimwegen, RA van Soest… - Clinical …, 2016 - academic.oup.com
BACKGROUND The substantial technological advancements in next-generation
sequencing (NGS), combined with dropping costs, have allowed for a swift diffusion of NGS …

The future of precision medicine: potential impacts for health technology assessment

J Love-Koh, A Peel, JC Rejon-Parrilla, K Ennis… - …, 2018 - Springer
Objective Precision medicine allows healthcare interventions to be tailored to groups of
patients based on their disease susceptibility, diagnostic or prognostic information, or …

[HTML][HTML] Clinical application of genome and exome sequencing as a diagnostic tool for pediatric patients: a scoping review of the literature

HS Smith, JM Swint, SR Lalani, JM Yamal… - Genetics in …, 2019 - Elsevier
Purpose Availability of clinical genomic sequencing (CGS) has generated questions about
the value of genome and exome sequencing as a diagnostic tool. Analysis of reported CGS …

Cost-effectiveness analyses of genetic and genomic diagnostic tests

K Payne, SP Gavan, SJ Wright… - Nature Reviews Genetics, 2018 - nature.com
Developments in next-generation sequencing technologies have driven the clinical
application of diagnostic tests that interrogate the whole genome, which offer the chance to …

Clinical utility of genomic sequencing: a measurement toolkit

RZ Hayeems, D Dimmock, D Bick, JW Belmont… - NPJ genomic …, 2020 - nature.com
Whole-genome sequencing (WGS) is positioned to become one of the most robust
strategies for achieving timely diagnosis of rare genomic diseases. Despite its favorable …

The economic case for precision medicine

SP Gavan, AJ Thompson, K Payne - Expert review of precision …, 2018 - Taylor & Francis
Introduction: The advancement of precision medicine into routine clinical practice has been
highlighted as an agenda for national and international health care policy. A principle barrier …

Economic evaluations of predictive genetic testing: A scoping review

Q Xi, S Jin, S Morris - PLoS One, 2023 - journals.plos.org
Predictive genetic testing can provide information about whether or not someone will
develop or is likely to develop a specific condition at a later stage in life. Economic …